Literature DB >> 3092669

Intrauterine intravascular transfusions for severe red blood cell isoimmunization: ultrasound-guided percutaneous approach.

R L Berkowitz, U Chitkara, J D Goldberg, I Wilkins, F A Chervenak, L Lynch.   

Abstract

Eight pregnancies with severe red blood cell isoimmunization were managed with use of an intravascular approach for intrauterine transfusions. Fetoscopy was not employed, and the procedures were performed percutaneously under direct ultrasound visualization. A total of 16 of 18 attempted transfusions were successfully performed, with four fetuses requiring more than one transfusion. Technical aspects of the procedure as well as its indications, advantages, and drawbacks are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3092669     DOI: 10.1016/0002-9378(86)90282-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Consequences of fetomaternal haemorrhage after intrauterine transfusion.

Authors:  U Nicolini; N K Kochenour; P Greco; E A Letsky; R D Johnson; M Contreras; C H Rodeck
Journal:  BMJ       Date:  1988-11-26

2.  Use of intravascular transfusion to treat hydrops fetalis in a moribund fetus.

Authors:  C R Harman; F A Manning; J M Bowman; I R Lange; S M Menticoglou
Journal:  CMAJ       Date:  1988-05-01       Impact factor: 8.262

3.  Fetal intracardiac transfusions in patients with severe rhesus isoimmunisation.

Authors:  M Westgren; A Selbing; M Stangenberg
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-26

Review 4.  Intrauterine transfusion with red cells and platelets.

Authors:  K J Moise
Journal:  West J Med       Date:  1993-09

5.  Diagnosis and treatment of fetal anemia due to isoimmunization.

Authors:  B Plöckinger; I Strümpflen; J Deutinger; G Bernaschek
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

Review 6.  Ethical considerations in prenatal diagnosis.

Authors:  E A Gates
Journal:  West J Med       Date:  1993-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.